Multikinase inhibitors for use in the treatment of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8609640
APP PUB NO 20090082313A1
SERIAL NO

12180408

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compounds, pharmaceutical compositions and methods for the treatment of specific cancers. Such compositions may generally comprise a compound of formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EISAI INC100 TICE BLVD WOODCLIFF LAKE NJ 07677

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Agoulnik, Sergei Wilmington, US 9 87
Decosta, Bruce Salem, US 9 34
Du, Hong North Andover, US 41 264
Jiang, Yimin Londonderry, US 75 1285
Li, Xiang-Yi Andover, US 15 142
Nomoto, Kenichi Belmont, US 22 111
Wang, John (Yuan) Andover, US 11 41
Wu, Jiayi Brookline, US 22 182
Zhang, Huiming Andover, US 39 264

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 17, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00